AbstractBackground and purposeWe try to search for specific serum or urinary biomarkers for the early detection, follow-up, and prediction of tumor recurrence, progression, and clinical outcome is a difficult task in individuals with bladder cancer.Materials and methodsIn this study, urinary samples were dialyzed to remove any interfering molecules and concentration by lyophilization. The urinary proteome maps of 10 healthy volunteers and 10 bladder transitional cell carcinoma (BTTC) patients were explored through two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) coupled with mass spectrometry. With no fractionation, the proteome maps acquired in this study likely represented the total urinary proteins.ResultsComparative proteom...
Detecting prostate cancer (PCa) using non-invasive diagnostic markers still remains a challenge. The...
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the w...
Bladder cancer is currently the fourth most common cancer, the sixth most common cause of cancer dea...
AbstractBackground and purposeWe try to search for specific serum or urinary biomarkers for the earl...
Urinary bladder cancer is a heterogeneous disease appearing in different forms, e.g. non-muscle inva...
AbstractIn this study, we evaluated the reproducibility of abundant urine protein depletion by hexap...
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated comp...
<div><p>We used protein expression profiles to develop a classification rule for the detection and p...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their ...
Bladder cancer (BC) is the most common tumor of the urinary tract and is conventionally classified a...
<p>The proteomic profile of bladder cancer development from <i>in situ</i> neoplasia was developed o...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their...
Urine is an ideal medium in which to focus diagnostic cancer research due to the non-invasive nature...
Background. Though there are several prognostic models, there is no protein-related prognostic model...
Detecting prostate cancer (PCa) using non-invasive diagnostic markers still remains a challenge. The...
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the w...
Bladder cancer is currently the fourth most common cancer, the sixth most common cause of cancer dea...
AbstractBackground and purposeWe try to search for specific serum or urinary biomarkers for the earl...
Urinary bladder cancer is a heterogeneous disease appearing in different forms, e.g. non-muscle inva...
AbstractIn this study, we evaluated the reproducibility of abundant urine protein depletion by hexap...
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated comp...
<div><p>We used protein expression profiles to develop a classification rule for the detection and p...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their ...
Bladder cancer (BC) is the most common tumor of the urinary tract and is conventionally classified a...
<p>The proteomic profile of bladder cancer development from <i>in situ</i> neoplasia was developed o...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their...
Urine is an ideal medium in which to focus diagnostic cancer research due to the non-invasive nature...
Background. Though there are several prognostic models, there is no protein-related prognostic model...
Detecting prostate cancer (PCa) using non-invasive diagnostic markers still remains a challenge. The...
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the w...
Bladder cancer is currently the fourth most common cancer, the sixth most common cause of cancer dea...